Tanner Health and Healthliant Ventures partner with Optellum to launch an artificial intelligence (AI) platform designed to detect lung cancer.
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier ...
Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...
Survival outcomes in non-small cell lung cancer: Real-world analysis of immunotherapy era vs pre-immunotherapy era, with insights into treatment settings, racial disparities, and socioeconomic impacts ...
Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...
Explore whether Canakinumab can prevent lung cancer, focusing on new research and the complexities of medical interpretations ...
As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results